NRT Smoking Cessation Aids in New Zealand

Table of Contents

• List of Contents and Tables
• OTC HEALTHCARE IN NEW ZEALAND
• Executive Summary
• A Year of Limited Growth
• Consumers Increasingly Prepared To Self-medicate
• OTC Obesity - the Rising Star
• Pharmacies Set To Regain Lost Share
• Consolidation Continues
• Sound and Sustainable Forecast
• Key Trends and Developments
• De-regulations Encourage Consumers for Self-medication
• Pharmacies Fighting Back To Secure Top Position in OTC Retailing
• Ageing Population Stimulates OTC Sales
• Continually Changing Face of OTC Environment
• Preventive Measures Key To Shaping Demand for OTC Healthcare Products
• Market Indicators
  • Table 1 Life Expectancy at Birth 2001-2006
• Market Data
  • Table 2 Sales of OTC Healthcare by Sector: Value 2001-2006
  • Table 3 Sales of OTC Healthcare by Sector: % Value Growth 2001-2006
  • Table 4 OTC Healthcare Company Shares by Retail Value 2002-2006
  • Table 5 OTC Healthcare Brand Shares by Retail Value 2003-2006
  • Table 6 Penetration of Private Label by Sector 2002-2006
  • Table 7 Sales of OTC Healthcare by Distribution Format: % Analysis 2001/2006
  • Table 8 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2006
  • Table 9 Forecast Sales of OTC Healthcare by Sector: Value 2006-2011
  • Table 10 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2006-2011
• Appendix
• OTC Registration and Classification
• Vitamins & Dietary Supplements Registration and Classification
• Generics
• Consumer Expenditure on Health Goods and Medical Services
• Consumer Expenditure on Health Goods and Medical Services
  • Table 11 Consumer Expenditure on Health Goods and Medical Services 2001-2006
• Definitions
• Sources
  • Summary 1 Research Sources
• LOCAL COMPANY PROFILES - NEW ZEALAND
• Apotex Nz Ltd
• Strategic Direction
• Key Facts
  • Summary 2 Apotex NZ Ltd: Key Facts
  • Summary 3 Apotex NZ Ltd: Operational Indicators
• Company Background
• Production
• Competitive Positioning
  • Summary 4 Apotex NZ Ltd: Competitive Position 2006
• Douglas Pharmaceuticals Ltd
• Strategic Direction
• Key Facts
  • Summary 5 Douglas Pharmaceuticals Ltd: Key Facts
• Company Background
• Production
  • Summary 6 Douglas Pharmaceuticals Ltd: Production Statistics 2006
• Competitive Positioning
  • Summary 7 Douglas Pharmaceuticals Ltd: Competitive Position 2006
• Ebos Ltd
• Strategic Direction
• Key Facts
  • Summary 8 Ebos Group Ltd: Key Facts
  • Summary 9 Ebos Group Ltd: Operational Indicators
• Company Background
• Production
• Competitive Positioning
  • Summary 10 Ebos Group Ltd: Competitive Position 2006
• Healtheries of New Zealand Ltd
• Strategic Direction
• Key Facts
  • Summary 11 Healtheries of New Zealand Ltd: Key Facts
  • Summary 12 Healtheries of New Zealand Ltd: Operational Indicators
• Company Background
• Production
  • Summary 13 Healtheries of New Zealand Ltd: Production Statistics 2006
• Competitive Positioning
  • Summary 14 Healtheries of New Zealand Ltd: Competitive Position 2006
• Life Pharmacy Ltd
• Strategic Direction
• Key Facts
  • Summary 15 Life Pharmacy Ltd: Key Facts
  • Summary 16 Life Pharmacy Ltd: Operational Indicators
• Company Background
• NRT SMOKING CESSATION AIDS IN NEW ZEALAND
• Headlines
• Trends
• Competitive Landscape
• Prospects
• Sector Indicators
  • Table 12 Number of Smokers by Gender 2001-2006
• Sector Data
  • Table 13 Sales of Smoking Cessation Aids by Subsector: Value 2001-2006
  • Table 14 Sales of Smoking Cessation Aids by Subsector: % Value Growth 2001-2006
  • Table 15 Smoking Cessation Aids Company Shares by Retail Value 2002-2006
  • Table 16 Smoking Cessation Aids Brand Shares by Retail Value 2003-2006
  • Table 17 Forecast Sales of Smoking Cessation Aids by Subsector: Value 2006-2011
  • Table 18 Forecast Sales of Smoking Cessation Aids by Subsector: % Value Growth 2006-2011
• NRT Smoking cessation aids New Zealand